Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-24 @ 9:21 PM
NCT ID:
NCT04921904
Eligibility Criteria:
Subjects must meet all eligibility criteria. The key inclusion and exclusion criteria are as follows:
Key Inclusion Criteria:
* All subjects must have metastatic esophageal or gastroesophageal junction carcinomas (adenocarcinoma only)
* ECOG performance status of 0 or 1
* Tumor tissue must be available for correlative studies - Either a formalin fixed paraffin block or a minimum of ten 5-micron tissue section's (slides) of tumor biopsy sample must be available for biomarker evaluation.
* Patients must have received at least one prior line of standard systemic therapy for recurrent or Stage IV disease, and that patients with HER2 overexpression have received an anti-HER2 drug.
Key Exclusion Criteria:
* Squamous cell carcinomas
* Mixed histology with small cell component
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04921904
Study Brief:
Protocol Section:
NCT04921904